Sunshine Biopharma, Inc. (SBFM) Tops Q3 EPS by 2c

Sunshine Biopharma, Inc. (NASDAQ: SBFM) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $5.96 million versus the consensus estimate of $6 million.

For earnings history and earnings-related data on Sunshine Biopharma, Inc. (SBFM) click here.

You May Also Be Interested In

• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• SeaStar Medical (ICU) Misses Q1 EPS by 4c